Scott Power on Biota merger
ASX-listed Biota Holdings (BTA) has signed off on a merger with US pharmaceuticals company Nabi, giving BTA access to the American market for its Relenza flu vaccine and a listing on NASDAQ.
Morgans Senior Analyst Scott Power spoke to ABC's The Business following news of the agreement.
Watch the video on ABC.net.au.
Clients can view all of our previous analysis on Biota, however we will no longer be covering Biota with its move to the NASDAQ.
Print this page